Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$72.96 - $84.0 $3.09 Million - $3.56 Million
-42,364 Reduced 21.32%
156,315 $13.1 Million
Q2 2024

Aug 13, 2024

BUY
$67.33 - $77.71 $5.67 Million - $6.54 Million
84,182 Added 73.52%
198,679 $15.3 Million
Q1 2024

May 14, 2024

BUY
$57.6 - $68.62 $431,827 - $514,444
7,497 Added 7.01%
114,497 $7.84 Million
Q4 2023

Feb 13, 2024

BUY
$48.64 - $57.81 $5.2 Million - $6.19 Million
107,000 New
107,000 $6.19 Million
Q2 2022

Aug 12, 2022

SELL
$35.24 - $47.1 $8.81 Million - $11.8 Million
-250,000 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $10.2 Million - $11.3 Million
250,000 New
250,000 $11.1 Million
Q2 2021

Aug 13, 2021

SELL
$38.58 - $44.24 $5.79 Million - $6.64 Million
-150,000 Closed
0 $0
Q1 2021

Feb 24, 2022

BUY
$35.27 - $39.67 $5.29 Million - $5.95 Million
150,000 New
150,000 $5.8 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Eisler Capital (Uk) Ltd. Portfolio

Follow Eisler Capital (Uk) Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eisler Capital (Uk) Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Eisler Capital (Uk) Ltd. with notifications on news.